Don Hardison

Biotheranostics has appointed Don Hardison as CEO, succeeding Nicolas Barthelemy. Hardison originally joined Biotheranostics in July 2016 as part of its board of directors. Most recently, he served as president, CEO, and director of Good Start Genetics. He has also served as CEO of Exact Sciences and held senior leadership roles at Laboratory Corporation of America, Quest Diagnostics, and SmithKline Beecham.


John Marshall

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.